The U.S. Food and Drug Administration has approved a version of leucovorin made by GlaxoSmithKline, years after the company pulled the drug from consideration when it stopped manufacturing it. The ...

A new study has discovered that drugs for diabetes and weight loss could significantly reduce mortality for Americans. Researchers at Swiss Re, a reinsurance company in Zurich, Switzerland, released ...

One of neurologist Anelyssa D’Abreu’s least favorite tasks is giving her patients a dreaded diagnosis: early-stage Alzheimer’s disease. But it’s not quite as bad as it used to be. Today when they ask, ...

Past studies have suggested that GLP-1 receptor agonists may inhibit inflammatory processes in addition to their metabolic effects./> This study examined medical records for overweight/obese ...

Health and Human Services Secretary Robert F. Kennedy Jr. reaffirmed his belief that violent video games may be a factor in the rise of mass shootings in the U.S. Kennedy on Tuesday held a meeting ...

The Trump administration is steering the nation's health agenda in a sharply new direction, urging federal agencies to focus on vaccine safety and the causes of autism under a plan unveiled Tuesday by ...

We've all heard about the uncomfortable side effects that come with taking GLP-1 medications like Ozempic and Wegovy: upset stomach, constipation, nausea, hair loss... The list goes on. But ...

A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical ...

Dianthus Therapeutics Inc. (NASDAQ:DNTH) released topline data from the Phase 2 MaGic trial evaluating the safety and efficacy of claseprubart (DNTH103) in adults with acetylcholine receptor ...

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic ...